A multicenter, randomized clinical trial comparing the three-weekly docetaxel regimen plus prednisone versus mitoxantone plus prednisone for Chinese patients with metastatic castration refractory prostate cancer.

<h4>Purpose</h4>To explore the feasibility and efficacy of docetaxel plus prednisone for Chinese population with metastatic castration refractory prostate cancer (mCRPC).<h4>Patients and methods</h4>A total of 228 patients recruited from 15 centers were randomized to receive 10 cycles of D3P arm (do...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Tie Zhou, Shu-xiong Zeng, Ding-wei Ye, Qiang Wei, Xu Zhang, Yi-ran Huang, Zhang-qun Ye, Yong Yang, Wei Zhang, Ye Tian, Fang-jian Zhou, Jin Jie, Shi-ping Chen, Yan Sun, Li-ping Xie, Xing Yao, Yan-qun Na, Ying-hao Sun
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Public Library of Science (PLoS) 2015-01-01
Ráidu:	PLoS ONE
Liŋkkat:	https://doi.org/10.1371/journal.pone.0117002
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!